Finance

Lists
011040:KOSDAQ
Kyung Dong Pharmaceutical Co Ltd
â‚©5,050.00
+1.00%
(+50.00) 1D
Oct 19, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 011040...
Open
â‚©5,000
High
â‚©5,050
Low
â‚©4,985
Mkt. cap
155.38B
Avg. vol.
124.34K
Volume
26.03K
Dividend
5.94%
Quarterly dividend
â‚©75
Ex-dividend date
Dec 29, 2025
P/E ratio
7.80
52-wk high
â‚©6,270
52-wk low
â‚©4,700
EPS
â‚©647
Shares outstanding
30.77M
No. of employees
332
Open
â‚©5,000
High
â‚©5,050
Low
â‚©4,985
Mkt. cap
155.38B
Avg. vol.
124.34K
Volume
26.03K
Dividend
5.94%
Quarterly dividend
â‚©75
Ex-dividend date
Dec 29, 2025
P/E ratio
7.80
52-wk high
â‚©6,270
52-wk low
â‚©4,700
EPS
â‚©647
Shares outstanding
30.77M
No. of employees
332
News stories
From web sources and news partners
About Kyung Dong Pharmaceutical Co Ltd
CEORyu Deok-Hee
Employees332
Founded1975
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
48.88B
52.16B
47.81B
52.26B
Cost of goods sold
19.32B
21.72B
18.17B
19.79B
Cost of revenue
19.32B
21.72B
18.17B
19.79B
Research and development expenses
1.03B
2.48B
2.27B
2.55B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.04B
24.95B
24.33B
25.71B
Operating expense
26.47B
27.88B
27.23B
28.77B
Total operating expenses
45.79B
49.59B
45.40B
48.56B
Operating income
3.09B
2.57B
2.41B
3.70B
Other non operating income
-9.54M
-275.41M
-525.56M
51.44M
EBT including unusual items
5.06B
3.38B
5.79B
7.01B
EBT excluding unusual items
3.17B
2.55B
3.66B
4.71B
Income tax expense
651.02M
545.55M
1.07B
1.25B
Effective tax rate
12.86%
16.12%
18.43%
17.86%
Other operating expenses
102.45M
125.84M
292.56M
156.19M
Net income
4.42B
2.89B
4.74B
5.78B
Net profit margin
9.04%
5.53%
9.92%
11.06%
Earnings per share
-
-
-
-
Interest and investment income
545.11M
569.79M
1.20B
322.29M
Interest expense
-454.94M
-411.90M
-430.01M
-420.06M
Net interest expenses
90.17M
157.89M
766.62M
-97.76M
Depreciation and amortization charges
211.15M
233.68M
226.64M
223.10M
EBITDA
4.03B
3.56B
3.43B
4.73B
Gain or loss from assets sale
-1.35B
-926.68M
-
-444.42M
AI content may include mistakes. Learn more
Google apps